SIONNA THERAPEUTICS, INC. Earnings Per Share (Basic)
SIONNA THERAPEUTICS, INC. (SION) reported Earnings Per Share (Basic) of -$0.66 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- SIONNA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.66.
- SIONNA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.60.
- SIONNA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.46.
- SIONNA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.46.
- SIONNA THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$1.88.
- SIONNA THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$15.99.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.66 10-Q · filed 2026-08-06 | -$1.25 10-Q · filed 2026-08-06 | -$1.72 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.18 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2026-03-31 | -$0.60 10-Q · filed 2026-05-12 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.51 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.92 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-12-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$1.33 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.88 10-K · filed 2026-03-02 | ||
| 2025-09-30 | -$0.46 10-Q · filed 2025-11-05 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.43 10-Q · filed 2025-11-05 | -$2.36 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-06-30 | -$0.41 10-Q · filed 2026-08-06 | -$410.00 10-Q · filed 2025-08-11 | -$0.98 10-Q · filed 2026-08-06 | -$980.00 10-Q · filed 2025-08-11 | -$2.00 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.80 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$0.62 10-Q · filed 2026-05-12 | -$620.00 10-Q · filed 2025-05-12 | -$2.07 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$4.84 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$6.81 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2024-12-31 | -$3.37 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$8.99 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$12.11 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$15.99 10-K · filed 2026-03-02 | ||
| 2024-09-30 | -$5.67 10-Q · filed 2025-11-05 | -$8.89 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$12.81 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | -$2710.00 10-Q · filed 2025-08-11 | -$6540.00 10-Q · filed 2025-08-11 | ||||
| 2024-03-31 | -$3840.00 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |